Skip to main content
Clinical Trials/NCT04299841
NCT04299841
Withdrawn
Not Applicable

Stress Disorder Post-stroke: Observational Study of the Evaluation of Post Traumatic Stress Post Stroke (Stroke Post Traumatic Disorder)

Ch Mont de Marsan1 site in 1 countryMarch 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Post Traumatic Stress Disorder
Sponsor
Ch Mont de Marsan
Locations
1
Primary Endpoint
Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 months after stroke
Status
Withdrawn
Last Updated
4 years ago

Overview

Brief Summary

This prospective, observational, multicentre study evaluates the existence of Post-traumatic stress disorder following a stroke at 3 and 6 months after the management of the patient.

Questionnaires will be used to assess the presence of stroke post traumatic disorder.

The evaluation of stroke post traumatic disorder would allow to underline the importance of the awareness of the care teams in the the screening of these disorders and to evaluate if the Post-traumatic Stress Disorder Checklist Scale (PCL5) is an effective screening tool.

Registry
clinicaltrials.gov
Start Date
March 2021
End Date
December 1, 2021
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Ch Mont de Marsan
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Patient age \> 18years old
  • Patient registered with a social security scheme
  • Patient who was given a written information and who gave his/her non-opposition
  • Patient who was hospitalized with a diagnosis of stroke in the neurology department and oriented to the post-stroke consultation (3 months after the hospital discharge) or un the follow-up care and readaptation department of hospital center of Dax or Mont de Marsan

Exclusion Criteria

  • Patient with a serious disability sequelae (mRS\>3),
  • Patient without enough level of proficiency in the French language,
  • Patient with neurocognitive and neurocognitive disorder diagnosed,
  • Patient with history of significant psychiatric disorders diagnosed,
  • Patient with seve aphasia

Outcomes

Primary Outcomes

Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 months after stroke

Time Frame: at time of inclusion (3 months after stroke)

Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 months after stroke. This evaluation will be made by completion of PCL-5 questionnaire (Post-traumatic stress disorder checklist version DSM-5 (DSM:Diagnostic and Statistical Manuel of Mental Disorders)). A PCL-5 positive score will be an indicator of post-traumatic stress disorder correlated with stroke.

Secondary Outcomes

  • Evaluate the number of patients managed for stroke and presenting Stroke Post Traumatic Disorder at 3 and at 6 months(at time of inclusion (3 months after stroke) and 6 months after stroke (study participation duration for patient: 3 months))
  • Evaluate the number of patients under antidepressant or anxiolytics treatment before the stroke(at time of inclusion (3 months after stroke))
  • Evaluate the existence of a peritraumatic dissociation at the time of the occurrence of the stroke(at time of inclusion (3 months after stroke))
  • Evaluate the number of patients presenting a depressive state at 3 months(at time of inclusion (3 months after stroke))
  • Evaluate the PCL-5 questionnaire as a screening tool of the stroke post traumatic disorder(at time of inclusion (3 months after stroke) and 6 months after stroke (study participation duration for patient: 3 months))
  • Evaluate the traumatic history of the patient before the occurrence of the stroke(at time of inclusion (3 months after stroke))

Study Sites (1)

Loading locations...

Similar Trials